Literature DB >> 28038337

Common data elements and data management: Remedy to cure underpowered preclinical studies.

Niina Lapinlampi1, Esbjörn Melin2, Eleonora Aronica3, Jens P Bankstahl4, Albert Becker5, Cristophe Bernard6, Jan A Gorter3, Olli Gröhn1, Anu Lipsanen1, Katarzyna Lukasiuk7, Wolfgang Löscher8, Jussi Paananen9, Teresa Ravizza10, Paolo Roncon11, Michele Simonato11, Annamaria Vezzani10, Merab Kokaia2, Asla Pitkänen12.   

Abstract

Lack of translation of data obtained in preclinical trials to clinic has kindled researchers to develop new methodologies to increase the power and reproducibility of preclinical studies. One approach relates to harmonization of data collection and analysis, and has been used for a long time in clinical studies testing anti-seizure drugs. EPITARGET is a European Union FP7-funded research consortium composed of 18 partners from 9 countries. Its main research objective is to identify biomarkers and develop treatments for epileptogenesis. As the first step of harmonization of procedures between laboratories, EPITARGET established working groups for designing project-tailored common data elements (CDEs) and case report forms (CRFs) to be used in data collection and analysis. Eight major modules of CRFs were developed, presenting >1000 data points for each animal. EPITARGET presents the first single-project effort for harmonization of preclinical data collection and analysis in epilepsy research. EPITARGET is also anticipating the future challenges and requirements in a larger-scale preclinical harmonization of epilepsy studies, including training, data management expertise, cost, location, data safety and continuity of data repositories during and after funding period, and incentives motivating for the use of CDEs.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Common data element; Data management; Database; Epilepsy; Epileptogenesis

Mesh:

Substances:

Year:  2016        PMID: 28038337     DOI: 10.1016/j.eplepsyres.2016.11.010

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  13 in total

1.  Harmonization of pipeline for preclinical multicenter plasma protein and miRNA biomarker discovery in a rat model of post-traumatic epileptogenesis.

Authors:  Alaa Kamnaksh; Noora Puhakka; Idrish Ali; Gregory Smith; Roxanne Aniceto; Jesse McCullough; Shalini Das Gupta; Xavier Ekolle Ndode-Ekane; Rhys Brady; Pablo Casillas-Espinosa; Matt Hudson; Cesar Santana-Gomez; Riikka Immonen; Pedro Andrade de Abreu; Nigel Jones; Sandy Shultz; Richard J Staba; Terence J O'Brien; Denes Agoston; Asla Pitkänen
Journal:  Epilepsy Res       Date:  2018-11-26       Impact factor: 3.045

2.  Premise for Standardized Sepsis Models.

Authors:  Daniel G Remick; Alfred Ayala; Irshad H Chaudry; Craig M Coopersmith; Clifford Deutschman; Judith Hellman; Lyle Moldawer; Marcin F Osuchowski
Journal:  Shock       Date:  2019-01       Impact factor: 3.454

3.  Harmonization of the pipeline for seizure detection to phenotype post-traumatic epilepsy in a preclinical multicenter study on post-traumatic epileptogenesis.

Authors:  Pablo M Casillas-Espinosa; Pedro Andrade; Cesar Santana-Gomez; Tomi Paananen; Gregory Smith; Idrish Ali; Robert Ciszek; Xavier Ekolle Ndode-Ekane; Rhys D Brady; Jussi Tohka; Matthew R Hudson; Piero Perucca; Emma L Braine; Riikka Immonen; Noora Puhakka; Sandy R Shultz; Nigel C Jones; Richard J Staba; Asla Pitkänen; Terence J O'Brien
Journal:  Epilepsy Res       Date:  2019-04-27       Impact factor: 3.045

4.  Web-Based Application for Biomedical Image Registry, Analysis, and Translation (BiRAT).

Authors:  Rahul Pemmaraju; Robert Minahan; Elise Wang; Kornel Schadl; Heike Daldrup-Link; Frezghi Habte
Journal:  Tomography       Date:  2022-05-30

5.  Informatics tools to assess the success of procedural harmonization in preclinical multicenter biomarker discovery study on post-traumatic epileptogenesis.

Authors:  Robert Ciszek; Xavier Ekolle Ndode-Ekane; Cesar Santana Gomez; Pablo M Casillas-Espinosa; Idrish Ali; Gregory Smith; Noora Puhakka; Niina Lapinlampi; Pedro Andrade; Alaa Kamnaksh; Riikka Immonen; Tomi Paananen; Matthew R Hudson; Rhys D Brady; Sandy R Shultz; Terence J O'Brien; Richard J Staba; Jussi Tohka; Asla Pitkänen
Journal:  Epilepsy Res       Date:  2018-12-27       Impact factor: 3.045

Review 6.  Preface - Practical and theoretical considerations for performing a multi-center preclinical biomarker discovery study of post-traumatic epileptogenesis: lessons learned from the EpiBioS4Rx consortium.

Authors:  Asla Pitkänen; Terence J O'Brien; Richard Staba
Journal:  Epilepsy Res       Date:  2019-01-18       Impact factor: 3.045

7.  A companion to the preclinical common data elements for physiologic data in rodent epilepsy models. A report of the TASK3 Physiology Working Group of the ILAE/AES Joint Translational Task Force.

Authors:  Jan A Gorter; Erwin A van Vliet; Stefanie Dedeurwaerdere; Gordon F Buchanan; Daniel Friedman; Karin Borges; Heidi Grabenstatter; Katarzyna Lukasiuk; Helen E Scharfman; Astrid Nehlig
Journal:  Epilepsia Open       Date:  2018-10-11

8.  Evaluation of subchronic administration of antiseizure drugs in spontaneously seizing rats.

Authors:  Kyle E Thomson; Cameron S Metcalf; Thomas G Newell; Jennifer Huff; Sharon F Edwards; Peter J West; Karen S Wilcox
Journal:  Epilepsia       Date:  2020-05-18       Impact factor: 6.740

9.  A companion to the preclinical common data elements for pharmacologic studies in animal models of seizures and epilepsy. A Report of the TASK3 Pharmacology Working Group of the ILAE/AES Joint Translational Task Force.

Authors:  Melissa Barker-Haliski; Lauren C Harte-Hargrove; Teresa Ravizza; Ilse Smolders; Bo Xiao; Claudia Brandt; Wolfgang Löscher
Journal:  Epilepsia Open       Date:  2018-09-15

10.  In Vitro and In Vivo Pipeline for Validation of Disease-Modifying Effects of Systems Biology-Derived Network Treatments for Traumatic Brain Injury-Lessons Learned.

Authors:  Anssi Lipponen; Teemu Natunen; Mika Hujo; Robert Ciszek; Elina Hämäläinen; Jussi Tohka; Mikko Hiltunen; Jussi Paananen; David Poulsen; Emilia Kansanen; Xavier Ekolle Ndode-Ekane; Anna-Liisa Levonen; Asla Pitkänen
Journal:  Int J Mol Sci       Date:  2019-10-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.